Restricted accessResearch articleFirst published online 2007-7
Il trattamento chirurgico dell'iperparatiroidismo nel paziente uremico: Ruolo attuale della paratiroidectomia: aspetti epidemiologici e nuove acquisizioni
National Kidney Foundation:K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis2003; 42: 1–201.
RitzE.Early parathyroidectomy should be considered as the first choice. Nephrol Dial Transplant1994; 9: 1819–21.
6.
CunninghamJ., DaneseM., OlsonK., KlassenP., ChertowG.M.Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int2005, 68: 1793–1800.
7.
BlockG.A., MartinK.J., de FranciscoA.L.Cinacalcet for secondary hyperparathyroid in patients receiving hemodialysis. N. Engl J Med2004, 350: 1516–25.
8.
MoeS.M., ChertowG.M., CoburnJ.W.Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinecalcet HCl. Kidney Int2005, 67: 760–771.
9.
BlockG.A., Hulbert-ShearonT.E., LevinN.W., PortF.K.Association of serum phosphorus and calcium phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis.1998; 31: 607–17.
10.
GaneshS.K., StackA.G., LevinN.W., Hulbert-ShearonT., PortF.K.Association of serum phosphorus and calcium x phosphorus product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol2001; 12: 2131–38.
11.
Rodriguez-BenotA., Martin-MaloA., Alvarez-LaraA., RodriquezM., AljamaP.Mild hyperphosphatemia and mortality in hemodialysis patients. Am J Kidney Dis2005; 46: 68–77.
12.
YoungE.W., AlbertJ.M., SatayathumS.Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int2005, 67: 1179–87.
13.
MelamedM.L., EustaceJa, PlantingaL.Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study. Kidney Int2006, 70: 351–7.
14.
Kalantar-ZadehK., KuwaeN., RegidorDlSurvival predictability of time-varying indicators of bone-disease in maintenance hemodialysis patients. Kidney Int2006, 70: 771–80.
15.
MalbertiF., MarcelliD., ConteF.Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol2001; 12: 1242–8.
16.
KestenbaumB., SeligerS.L., GillenD.L.Parathyroidectomy rates among United States dialysis patients: 1990–1999. Kidney Int2004, 65: 282–8.
17.
KestenbaumB., AndressD.L., SchwartzM.Survival following parathyroidectomy among United States dialysis patients. Kidney Int2004, 66: 2010–16.
18.
NarayanR., PerkinsR.M., BerbanoE.P.Parathyroidectomy versus cinacalcet hydrochloride-Dotzenrath C, Cupisti K, Goretzki E, et al. Operative treatnbase medical therapy in the management of hyperparathyroidism in ESRD: A cost utility analysis. Am J Kidney Dis2007, 49: 801–13.
19.
RichardsM.L., WormuthJ., BingenerJ., SirinekK.Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management ?Surgery2006; 139: 174–80.
20.
DotzenrathC., CupistiK., GoretzkiE.Operative treatment of renal autonomous hyperparathyroidism: Cause of persistent o recurrent disease. Langenbecks Arch Surg2003; 387: 348–54.
21.
NumanoM., TominagaY., UchidaK.Surgical significance of supernumerary parathyroid glands in renal hyperparathyroidism. Word J Srg1998; 22: 1098–1103.
22.
TominagaY., UchidaK., HabaT.More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis2001; 38, 1(Suppl.): S168–71.
23.
JofrèR., Lopez GomezJ.M., MenarguezJ.Parathyroidectomy: whom and when?Kidney Int2003, 85(Suppl): 100.
24.
PattouF.N., PellissierL.C., NoelC., WambergueF., HugloD.G., ProyeC.A.Supernumerary parathyroid glands: frequency and surgical significance in treatment of renal hyperparathyroidism. World J Surg.2000, 24: 1330–4.
25.
PunchJ.D., ThompsonN.W., MerionR.M.Subtotal parathyroidectomy in dialysis-dependent and post-renal transplant patients. A 25-year single-center experience. Arch Surg1995; 130: 538–43.
26.
EllisH.A.Fate of long-term parathyroid autografts in patients with chronic renal failure treated by PTx: A histopathological study of autografts, parathyroid glands and bone. Histopatol1988; 13: 289–309.
27.
ClaryB.M., GarnerS.C., LeightG.S.Intraoperative parathyroid hormone monitoring during parathyroidectomy for secondary hyperparathyroidism. Surgery1997, 122: 1034–8.
28.
RichardsM.L., GrantC.S.Current application of intraoperative parathyroid hormone assay in parathyroid surgery. Am Surgery2007; 73: 311–7.
29.
ThanasoulisL., BingenerJ., SirinekK., RichardsM.L.A successful application of the intraoperative parathyroid hormone assay (IOPTH) in tertiary hyperparathyroidism. Am Surg2007; 3: 281–3.
30.
HausteinS.V., MackE., StarlingJ., ChenH.The role of intraoperative parathyroid hormone esting in patients with tertiary hyperparathyroidism after renal transplantation. Surgery2005; 138: 1066–77.
31.
TakebayashiS., HidaiH., ChibaT.Hyperfunctional parathyroid glands with 99mTC-MIBI scan: semiquantitative analysis correlated with histologic findings. J Nucl Med1999; 40: 1792–97.
